The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
A Review of Chronic Granulomatous Disease
Open accessAbstract
Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by defects in any of the five subunits of the NADPH oxidase complex responsible for the respiratory burst in phagocytic leukocytes. Patients with CGD are at increased risk of life-threatening infections with catalase-positive bacteria and fungi and inflammatory complications such as CGD colitis. The implementation of routine antimicrobial prophylaxis and the advent of azole antifungals has considerably improved overall survival. Nevertheless, life expectancy remains decreased compared to the general population. Inflammatory complications are a significant contributor to morbidity in CGD, and they are often refractory to standard therapies. At present, hematopoietic stem cell transplantation (HCT) is the only curative treatment, and transplantation outcomes have improved over the last few decades with overall survival rates now > 90% in children less than 14 years of age. However, there remains debate as to the optimal conditioning regimen, and there is question as to how to manage adolescent and adult patients. The current evidence suggests that myeloablative conditioning results is more durable myeloid engraftment but with increased toxicity and high rates of graft-versus-host disease. In recent years, gene therapy has been proposed as an alternative to HCT for patients without an HLA-matched donor. However, results to date have not been encouraging. with negligible long-term engraftment of gene-corrected hematopoietic stem cells and reports of myelodysplastic syndrome due to insertional mutagenesis. Multicenter trials are currently underway in the United States and Europe using a SIN-lentiviral vector under the control of a myeloid-specific promoter, and, should the trials be successful, gene therapy may be a viable option for patients with CGD in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic Granulomatous Disease: Report on a National Registry of 368 Patients
Winkelstein, J. A., Marino, M. C., Johnston, R. B., Boyle, J., Curnutte, J., Gallin, J. I., Malech, H. L., Holland, S. M., Ochs, H., Quie, P., et al. (2000) · Medicine · doi:10.1097/00005792-200005000-00003 · Cited by 1,728
Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease
Kuhns, D. B., Alvord, W. G., Heller, T., Feld, J. J., Pike, K. M., Marciano, B. E., Uzel, G., DeRavin, S. S., Priel, D. A. L., Soule, B. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007097 · Cited by 568 · cited 2×
“More recent studies now report a survival rate of approximately 90% at 10 years of age, which has been attributed to improved recognition and early diagnosis leading to earlier therapies, including more efficacious antimicrobial prophylaxis, use of interferon-gamma (IFN-c) supplementation for infection prophylaxis, an…”
Backgroundde Luca, A., Smeekens, S. P., Casagrande, A., Iannitti, R., Conway, K. L., Gresnigt, M. S., Begun, J., Plantinga, T. S., Joosten, L. A. B., van der Meer, J. W. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322831111 · Cited by 313 · cited 1×
“IL-1R blockade using Anakinra resulted in rapid and sustained improvement of colitis in two patients with CGD [63].”
MethodDe Ravin, S. S., Li, L., Wu, X., Choi, U., Allen, C., Koontz, S., Lee, J., Theobald-Whiting, N., Chu, J., Garofalo, M., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah3480 · Cited by 258
De Ravin, S. S., Reik, A., Liu, P.-Q., Li, L., Wu, X., Su, L., Raley, C., Theobald, N., Choi, U., Song, A. H., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3513 · Cited by 195
Lee, P. P. W., Chan, K.-W., Jiang, L., Chen, T., Li, C., Lee, T.-L., Mak, P. H. S., Fok, S. F. S., Yang, X., & Lau, Y.-L. (2008) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31815b494c · Cited by 158
Cited by
Reactive Oxygen Species in Macrophages: Sources and Targets
Canton, M., Sánchez-Rodríguez, R., Spera, I., Venegas, F. C., Favia, M., Viola, A., & Castegna, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.734229 · Cited by 449
Acinetobacter baumannii OxyR Regulates the Transcriptional Response to Hydrogen Peroxide
Juttukonda, L. J., Green, E. R., Lonergan, Z. R., Heffern, M. C., Chang, C. J., & Skaar, E. P. (2019) · Infection and Immunity · doi:10.1128/iai.00413-18 · Cited by 75
“People who lack an effective neutrophil oxidative burst due to mutations in NADPH oxidase develop frequent and severe infections due to catalase-producing organisms, emphasizing the importance of the neutrophil oxidative burst in protection against infection (41).”
BackgroundMatta, S. K., Patten, K., Wang, Q., Kim, B.-H., MacMicking, J. D., & Sibley, L. D. (2018) · mBio · doi:10.1128/mbio.01393-18 · Cited by 52
Oxygen Is Instrumental for Biological Signaling: An Overview
Hancock, J. T. (2021) · Oxygen · doi:10.3390/oxygen1010002 · Cited by 24
Metadata
- Authors
- Arnold, D. E., & Heimall, J. R.
- Venue
- Advances in Therapy
- Published
- 2017-11-22
- Volume
- 34
- Issue
- 12
- Pages
- 2543-2557
- ISSN
- 0741-238X (ISSN-L)
- 1865-8652
- OpenAlex
- W2771001721
- Cited by
- 246
- References
- 6
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Review of Chronic Granulomatous Disease. https://app.cochat.ai/papers/10.1007/s12325-017-0636-2
- The paper
- Arnold, D. E., & Heimall, J. R. (2017). A Review of Chronic Granulomatous Disease. Advances in Therapy. https://doi.org/10.1007/s12325-017-0636-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.